- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
Geneoscopy generates $105m in series B funding
Labcorp backed a debt and equity round for the cancer diagnostics technology developer as it advances its screening platform torwards commercialisation.
Nov 19, 2021Daily Deal Round Up: November 18, 2021
Koch Disruptive Technologies helped molecular diagnostics system developer Sense Biodetection expand its latest round to $65m while Hilti bought portfolio company Fieldwire for $300m.
Nov 18, 2021Aohua organises $118m IPO
The Legend Capital-backed endoscope provider has gone public on the Shanghai Stock Exchange’s Star market.
Nov 18, 2021H1 stores $100m in series C funding
The DRx Capital-backed healthcare database developer scored fresh capital to increase its overall funding to over $190m.
Nov 18, 2021Cala Health modulates $77m in funding
The neuromodulation-focused Stanford spinout increased its overall funding to $145m in a round led by Ascension Ventures.
Nov 18, 2021Cala Health modulates $77m in funding
The neuromodulation device maker increased its overall funding to $145m in a round led by Ascension Ventures.
Nov 18, 2021Corporates embrace secondaries strategies
The venture capital market has expanded rapidly over the past few decades, maturing and diversifying with the development of a variety of investment strategies, including more widespread and sophisticated secondary transactions.
Nov 18, 2021Suzhou Sepax secures series D injection
Sinopharm, Sinovac Biotech and Gan & Lee Pharmaceuticals all took part in the liquid chromatography technology provider’s series D round.
Nov 18, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
